National Health Investors (NHI) FY2014 results: revenue $178 million, up 50.7% on the year
National Health Investors Inc. (NHI) reported revenue of $178 million for fiscal 2014, the year ended 31 December 2014, up 50.7% on the year before. Net income was $102 million, down 4.3%, and diluted earnings per share $3.04. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2015.
Revenue
$178 million
+50.7% on the year
FY2008FY2014
Operating margin
58.1%
67.5% a year earlier
FY2008FY2014
Net income
$102 million
-4.3% on the year
FY2008FY2014
Diluted EPS
$3.04
-18.7% on the year
FY2008FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
178
118
93.3
+50.7%
Operating income
103
79.5
72.8
+29.6%
Operating margin
58.1%
67.5%
78.1%
Interest expense
26.4
9.2
3.5
+185.8%
Pre-tax income
103
75.9
67.9
+35.9%
Income tax
0.1
0.1
0.3
0.0%
Effective tax rate
0.1%
0.2%
0.4%
Net income
102
106
90.7
-4.3%
Net margin
57.2%
90.1%
97.2%
Diluted EPS
$3.04
$3.74
$3.26
-18.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
126
104
86.3
+21.1%
Capital expenditure
533
655
111
-18.6%
Free cash flow
-407
-550
-24.3
Free cash flow margin
-229.3%
-467.2%
-26.1%
Cash from investing
-540
-626
-99.8
Cash from financing
406
524
6.8
-22.5%
Share-based compensation
2.0
2.3
2.2
-13.6%
Dividends paid
101
85.1
78.9
+18.2%
Dividend per share
$3.08
$2.90
$2.86
+6.2%
Diluted shares, weighted
33m
28m
28m
+17.7%
Shares outstanding at period end
37m
33m
28m
+13.4%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
1,040
767
457
+35.7%
Non-controlling interest
10.0
10.6
10.9
-5.7%
Debt
863
617
203
+39.8%
Other liabilities
70.3
61.6
34.7
+14.2%
Total liabilities and equity
1,983
1,456
706
+36.2%
Fixed assets
1,777
1,248
n/a
+42.4%
Loans
63.6
60.6
84.2
+4.9%
Cash and equivalents
3.1
11.3
9.2
-72.7%
Receivables
3.8
2.5
1.8
+52.6%
Other assets
136
134
611
+1.7%
Total assets
1,983
1,456
706
+36.2%
10-K for the year ended 31 December 2014, filed 17 February 2015: the filing.